Please try another search
Harvard Apparatus Regenerative Technology Inc., a clinical-stage biotechnology company, engages in developing regenerative-medicine treatments for disorders of the gastro-intestinal system and the airway resulting from cancer, trauma, or birth defects. The company’s pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Biostage, Inc. and changed its name to Harvard Apparatus Regenerative Technology Inc. in July 2023. Harvard Apparatus Regenerative Technology Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Jason Jing Chen | 60 | 2018 | Independent Vice Chairman |
David Green | 59 | 2012 | Director |
James E. Shmerling | 69 | 2018 | Independent Director |
Christine Finck | - | 2018 | Member of Scientific Advisory Board |
Ting Li | 46 | 2018 | Independent Director |
Stephen F. Badylak | - | 2023 | Chairman of Scientific Advisory Board |
Herman Sanchez | 48 | 2021 | Independent Director |
Charles S. Cox | - | 2018 | Member of Scientific Advisory Board |
Ronald J. Packard | 60 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review